Navigation Links
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
Date:6/22/2009

ubjects identified as responders to Amigal, treatment resulted in increased levels of the target enzyme (a-Gal A), as measured in white blood cells and in the kidney, and reduced levels of the target substrate (GL-3), as measured in renal interstitial capillary cells from kidney biopsies and in urine.

About Fabry Disease

Fabry disease is a lysosomal storage disorder caused by inherited genetic mutations in the GLA gene, which result in deficient activity of the enzyme alpha-galactosidase A (a-Gal A). Deficient a-Gal A activity leads to lysosomal accumulation of globotriaosylceramide (GL-3), which is believed to cause the various symptoms of Fabry disease, including pain, kidney failure and increased risk of heart attack and stroke. Amigal is designed to selectively bind to and stabilize a-Gal A, which facilitates proper trafficking of the enzyme to the lysosomes, where it is needed to break down GL-3.

Fabry disease is estimated to affect approximately 5,000 to 10,000 people in the developed world, but recent evidence suggests that the disease may be significantly under-diagnosed. The U.S. Food and Drug Administration's Office of Orphan Products Development has granted orphan designation for Amigal in the United States, and the European Commission has designated Amigal as an orphan medicinal product in the European Union.

Shire HGT Collaboration

In November 2007, Amicus entered into a strategic collaboration with Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of Shire plc, to jointly develop Amicus' three lead pharmacological chaperone compounds for lysosomal storage disorders, Amigal, Plicera and AT2220. Under the terms of the collaboration Shire will pay development and sales milestones up to a maximum of $390 million, and will also pay tiered, double digit royalties on net sales of the products. Shire also shares world-wide developmen
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... April 24, 2015  New technologies and online ... to educate themselves about products and companies. Likewise, ... techniques available to market researchers seeking insights into ... marketplace, it,s imperative that organizations adjust their consumer ... market opportunities, niches and growth fronts. ...
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... the "Global Biobanking Market 2015-2019" report to ... Biobanking market to grow at a CAGR of 7.07% ... market can be divided into two segments: Equipment and ... growth prospects of the Global Biobanking market for the ...
(Date:4/24/2015)... Hi-Tech Pharmaceuticals refutes the results from ... of reliable scientific principles and methods and therefore ... of adulteration. The FDA is resting its very, ... misguided hope, that Methylphenylethylamine is not found in ... multiple other studies and cannot be relied on ...
Breaking Medicine Technology:Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
(Date:4/25/2015)... On Friday, April 17, Interstate Batteries ... Best Implementation Award. This award is given to ... of RFID technology to improve its manufacturing, supply chain ... best demonstrates how RFID is delivering real value to ... Live! 2015 in San Diego, the RFID industries annual ...
(Date:4/24/2015)... Illinois (PRWEB) April 24, 2015 Multi ... includes septic tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 ... to start the program. This does not include any ... applicable. Save $25-$65 per person. If someone is part ... or two tanks totaling approximately 2500 gallons or more, ...
(Date:4/24/2015)... The Fastest Fat Loss Week Ever, released by Shaun Hadsall ... Fat Loss Diet, has been causing a lot of commotion ... to help one lose belly fat in only 25 days ... investigative review. , "Our Fastest Fat Loss Week Ever ... experimenting with these methods on their clients with great success. ...
(Date:4/24/2015)... The first step to transforming one’s ... For meditation and yoga teacher Stine Koppernæs, meditation and ... tools that allow her to experience more peace and ... a teacher since 2006, and through the years she ... being. , “I love sharing this way of finding ...
(Date:4/24/2015)... April 24, 2015 Integrative Therapeutics ... key pathways: immunity and cognition. , A unique ... helps set ProThrivers™ Wellness Flavonoid Complex apart from ... combination of ingredients to support antioxidation versus the ... unites curcumin, green tea extract, Resveratrol, Alpha-Glycosyl Isoquercitrin, ...
Breaking Medicine News(10 mins):Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 2Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 3Health News:Integrative Therapeutics Introduces Two ProThrivers™ Wellness Supplements with Specialty Ingredients from Kyowa Hakko USA 4
... The Female Health Company,(Amex: FHC ) announced ... which,implements the USAID | DELIVER PROJECT, for the delivery ... Agency for International,Development (USAID) programs., For many years, ... and condoms. The Agency developed an operational plan for,its ...
... mice show curcumin reduces heart enlargement and lowers odds ... -- Curcumin, an ingredient in the curry spice tumeric, ... of heart failure, Canadian researchers say. , The scientists ... General Hospital tested the effects of curcumin in mice ...
... carries same risk as other circulatory problems, experts say. ... suffering from age-related macular degeneration (AMD) have twice the ... researchers report. , The degenerative eye disease is the ... in developed countries and affects the center of the ...
... Inc. (Nasdaq: NHWK ), the leading provider of ... States,today announced that it will present at the Cowen ... 18, 2008, at 11:00 am EDT at the,Boston Marriott ... and,Chief Executive Officer, Andrea Clegg, Vice President of Finance ...
... TORONTO, Feb. 28 /PRNewswire-FirstCall/ - MDS Inc. (TSX: ... services to the global life,sciences markets, announced that ... on Thursday, March 6., The Company will ... P.,DeFalco, President and Chief Executive Officer and Douglas ...
... clubs across the country will become the "Gateway to,Healthy ... transform,their lives and take better care of themselves., ... Annual,Get Active America! program, participating health clubs will open ... can revitalize their lives and,benefit from the supportive environment ...
Cached Medicine News:Health News:The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units 2Health News:Curry Ingredient May Cut Cardiovascular Risks 2Health News:Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk 2Health News:Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk 3Health News:NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008 2Health News:Health Clubs Open Doors Free for 5th Annual Get Active America! Month and Become Gateway to Healthy Living 2Health News:Health Clubs Open Doors Free for 5th Annual Get Active America! Month and Become Gateway to Healthy Living 3
... a scientifically advanced nutritional formulation that ... full body health. MacularProtect Complete is ... and other advanced research. It features ... a broad foundation of antioxidants, such ...
... is a scientifically advanced multinutrient ... visual and full body health. ... nutrients, including a diverse array ... lutein, lycopene and OptiBerry and ...
Ocuvite® Lutein is an advanced antioxidant supplement formulated to provide nutritional support for the eye....
... The herbal extracts, vitamins, ... formula increases circulation to ocular ... maintains healthy function of the ... eye. This formula is optimized ...
Medicine Products: